Beamline Proposal & Experiment Guide
Guide to successful proposals and experiments at the Powder Diffraction beamline.
Showing 721 - 740 of 1435 results
Guide to successful proposals and experiments at the Powder Diffraction beamline.
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.
This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.
Physicist and cancer research Dr Mitra Safavi-Naeini, Macromolecular crystallography beamline scientist Dr Eleanor Campbell and Engineering Support Workshop Manager Bianca Shepherd have been chosen by Science and Technology Australia as the next Superstars of STEM
Researchers from La Trobe University have used the Australian Synchrotron to help identify a key mechanism in how SARS-CoV-2 damages lung tissue.
Research infrastructure will support research and development of advanced concrete.
Dr Helen Maynard-Casely will be taking neutron physics on a road trip
Historic memorandums of understanding on the peaceful use of nuclear with Thailand and Canada.
Spatz neutron reflectometer becomes 15th neutron scattering instrument that is used for studies of biological materials and other soft matter.
Senior electronics engineer from SESAME visits following donation of instrumentation to the Middle East's synchrotron in Jordan.
The project aims to engage the wider cultural heritage community in addition to our internal research.
Twenty-four participants from Asia and the Pacific travelled to ANSTO for an International Atomic Energy Agency Regional Training Course on ‘Production and preclinical evaluation of emerging cyclotron-based radiopharmaceuticals’